Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

, Frontiers Editorial Office

doi:10.3389/fncel.2024.1505362

RETRACTION article

Front. Cell. Neurosci. , 08 October 2024

Sec. Cellular Neuropathology

Volume 18 - 2024 | https://doi.org/10.3389/fncel.2024.1505362

Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

This article is a retraction of:

RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
1. Read original article

$\r\nFrontiers Editorial Office$ Frontiers Editorial Office^*

A Retraction of the Original Research Article
Santacruzamate A ameliorates AD-like pathology by enhancing ER stress tolerance through regulating the functions of KDELR and Mia40-ALR in vivo and in vitro

by Chen, L., Liu, Y.-c., Tan, H., Zhang, Y., Xu, J., Liu, W.-l., Li, Z.-y., and Li, W.-p. (2019). Front. Cell. Neurosci. 13:61. doi: 10.3389/fncel.2019.00061

The journal retracts the 04 March 2019 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.

This retraction was approved the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Citation: Frontiers Editorial Office (2024) Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro. Front. Cell. Neurosci. 18:1505362. doi: 10.3389/fncel.2024.1505362

Received: 02 October 2024; Accepted: 02 October 2024;
Published: 08 October 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good